ARGX · Argen X SE ADR
United States · RS rating 33 · As of 2026-10-14
| Price | 818.30 USD |
|---|---|
| 1-day change | +1.9% |
| RS rating (overall / 1M / 3M / 12M) | 33 / 14 / 44 / 49 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 46 / 32 / 21 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +14.3% |
| Distance from 52-week high | +22.7% |
| Market cap (USD) | $49.2B |